Retrospective Study
Copyright ©The Author(s) 2022.
World J Crit Care Med. May 9, 2022; 11(3): 149-159
Published online May 9, 2022. doi: 10.5492/wjccm.v11.i3.149
Table 2 Stress cardiomyopathy diagnosis, complications and outcomes by unit

Overall, n = 109
MSICU, (n = 49)
CCU, (n = 60)
P value1
Confirmed SC62 (56.9)12 (24.5)50 (83.3)< 0.0001
Clinical SC47 (43.1)37 (75.5)10 (16.7)
Hospital day of diagnosis1; median [IQR]2 [1-3]3 [2-4]1 [1-2]0.0002
Diagnostic Studies – n (%)
Cardiac catherization62 (56.9)12 (24.5)50 (83.3)< 0.001
Transthoracic echo109 (100)49 (100)60 (100)
Lowest ejection fraction – (%); median [IQR]35 [28-40]30 [30-40]35 [30-45]0.38
TTE anatomical variant- n (%)
Atypical22 (20.2)12 (24.5)10 (16.7)0.31
Typical87 (79.8)37 (75.5)50 (83.3)
Type of SC- n (%)< 0.001
Primary 43 (39.4)0 (0.0)43 (71.6)
Secondary66 (60.5)49 (100.0)17 (28.3)
EKG Findings- n (%)
Normal EKG21 (19.2)14 (28.6)7 (11.7)0.03
ST-Segment elevation54 (49.5)15 (30.6)39 (65.0)< 0.001
ST-Segment depression4 (3.7)2 (4.08)2 (3.3)1.00
T-Wave inversion23 (21.1)13 (26.5)10 (16.7)0.24
Other25 (22.9)14 (28.6)11 (18.3)0.25
Complications – n (%)
ECMO/IABP use3 (2.8)1 (2.0)2 (3.3)1.00
Inotrope use10 (9.2)7 (14.3)3 (5)0.11
New arrythmia14 (12.8)5 (10.2)9 (15.0)0.57
AKI37 (33.9)21 (42.9)16 (26.7)0.08
RRT14 (12.8)4 (8.2)2 (3.3)0.41
Acute respiratory failure – n (%)
Mechanical ventilation44 (40.4)29 (59.2)15 (25.0)< 0.001
NIPPV only15 (13.8)8 (16.3)7 (11.7)0.48
Shock – n (%)41 (37.6)29 (59.2)12 (20.0)< 0.001
Cardiogenic shock14 (12.8)5 (10.2)9 (15.0)0.46
Septic shock28 (25.7)23 (46.9)5 (8.3)< 0.001
Other shock2 (1.8)2 (4.1)0 (0.0)0.11
Follow-up echocardiogram- n (%)
Repeat echo (% Total)69 (63.3)30 (61.2)39 (65.0)0.69
Reversibility (% Echo)69 (100.0)30/30 (100.0)39/39 (100.0)1.00
Clinical SC patients
Repeat Echo (% Total)27/47 (57.4)21/47 (44.7)6/47 (12.8)0.01
Reversibility (% Echo)27/27 (100.0)21/21 (100.0)6/6 (100.0)1.00
Hospital outcomes – n (%)
In-hospital mortality15 (13.8)9 (18.4)6 (10)0.27
ICU mortality8 (7.3)3 (6.1)5 (8.3)0.73